PRWeb: PreCyte Awarded $3M NIH Grant to Develop Alzheimer's Diagnostic for Clinical Trial Support
PRWeb: PreCyte Awarded $2M NIH Grant to Develop Lung Cancer Diagnostic
PRWeb: PreCyte Awarded $300k from NIH to Develop an Assay for Drug Selection for Alzheimer’s Disease
CEOCFO Magazine: Interview with PreCyte CEO, Robert Lipshutz
GenomeWeb: PreCyte Awarded $300K NIH Grant to Develop Lung Cancer Diagnostic
GenomeWeb: PreCyte Awarded NIH Grant to Develop Cell-Based Alzheimer's Diagnostic
